OptimizeRx Corporation Common Stock (OPRX)
Stock · NASDAQ · Consumer Discretionary
$8.5as of 10/16/2026
Price chart
OPRX Signal Track Record
How signals performed across all stocks →What OPRX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 39 | -0.8% | 46% | September 21, 2026 |
| Bollinger Band Breakout | 20 | +4.9% | 60% | September 29, 2026 |
| Bollinger Band Breakdown | 19 | -1.3% | 47% | June 22, 2026 |
| 200-Day Moving Average TouchActive now | 3 | -11.1% | 33% | September 24, 2026 |
| Any 20-session window (baseline) | -1.0% | 48% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About OPRX
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand mes…
- Sector
- Consumer Discretionary
- Industry
- Business Services
- Employees
- 132
- Website
- www.optimizerx.com/
Fundamentals
- 1-day range
- $8.46$8.79
- Market cap
- $126.48M
- P/E (trailing)
- 35.08
- P/E (forward)
- 8.35
- EPS (trailing)
- $0.24
- Dividend yield
- —
- Beta
- 1.18
- Avg. volume
- 216.1K
- Dividend pay date
- May 14, 2018
How OptimizeRx Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 12, 2026 · via SEC EDGAR / Finnhub
Forecasts
5 analyst ratings
OptimizeRx Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- OPRXOptimizeRx Corporation Common Stock$8.5▼ 3.95%Market cap $126.48MP/E 35.08$4.54$22.25
- GRABWGrab Holdings Limited Warrant$0.0137▼ 23.89%Market cap $118.09MP/E —$0.0101$0.5094
- RYDERyde Group Ltd. Class A Ordinary Shares$0.655▼ 4.80%Market cap $139.37MP/E —$0.205$1.55
- SCORcomScore Inc. Common Stock$3.43▼ 14.89%Market cap $113.05MP/E 1.31$3.42$9.34
- RGPResources Connection Inc. Common Stock$2.55▼ 6.25%Market cap $144.66MP/E —$2.79$5.37
- DHXDHI Group Inc. Common Stock$4.85▼ 2.81%Market cap $178.41MP/E 175.61$1.44$5.19
- GETYGetty Images Holdings Inc. Class A Common Stock$0.019▲ 35.71%Market cap $184.80MP/E —$0.0111$3.21
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| OPRX OptimizeRx Corporation Common Stock | $126.48M | 35.08 | $8.5 | ▼ 3.95% | $4.54$22.25 |
| GRABW Grab Holdings Limited Warrant | $118.09M | — | $0.0137 | ▼ 23.89% | $0.0101$0.5094 |
| RYDE Ryde Group Ltd. Class A Ordinary Shares | $139.37M | — | $0.655 | ▼ 4.80% | $0.205$1.55 |
| SCOR comScore Inc. Common Stock | $113.05M | 1.31 | $3.43 | ▼ 14.89% | $3.42$9.34 |
| RGP Resources Connection Inc. Common Stock | $144.66M | — | $2.55 | ▼ 6.25% | $2.79$5.37 |
| DHX DHI Group Inc. Common Stock | $178.41M | 175.61 | $4.85 | ▼ 2.81% | $1.44$5.19 |
| GETY Getty Images Holdings Inc. Class A Common Stock | $184.80M | — | $0.019 | ▲ 35.71% | $0.0111$3.21 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- What Trade Desk (TTD)'s Healthcare Inventory Integration With OptimizeRx Means For ShareholdersYahoo · 10/2/2026
- B. Riley Securities Maintains Buy on OptimizeRx, Raises Price Target to $11Benzinga · 9/29/2026
- Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?Yahoo · 9/23/2026
- OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad NetworkYahoo · 9/22/2026
- OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPathYahoo · 9/22/2026
- OptimizeRx: Gross Margin Gains And Improved Long-Term OutlookSeekingAlpha · 9/18/2026
- OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience IntelligenceYahoo · 9/14/2026
Insider Activity
Insider Actions →- Andrew J. D'Silva · October 1, 2026 · Tax Withholding414 @ $8.39
- Andrew J. D'Silva · September 1, 2026 · Tax Withholding1.4K @ $7.86
- Brendan W. Merrell · August 21, 2026 · Tax Withholding1.0K @ $7.71
- Stephen L. Silvestro · August 21, 2026 · Tax Withholding1.7K @ $7.71
- Marion Odence-Ford · August 21, 2026 · Tax Withholding1.5K @ $7.71
- Andrew J. D'Silva · August 21, 2026 · Tax Withholding1.2K @ $7.71
- Edward Stelmakh · August 21, 2026 · Tax Withholding1.4K @ $7.71
- Stephen L. Silvestro · August 20, 2026 · Grant79.2K
- Andrew J. D'Silva · August 20, 2026 · Grant57.6K
- Brendan W. Merrell · August 20, 2026 · Grant57.6K
- Marion Odence-Ford · August 20, 2026 · Grant57.6K
- James Paul Lang · June 9, 2026 · Grant34.5K
- Mariyamma Varghese Presti · June 9, 2026 · Grant17.3K
- Ellen O'Connor Vos · June 9, 2026 · Grant34.5K
- Patrick D. Spangler · June 9, 2026 · Grant34.5K
Institutional Ownership
March 31, 2026
- Total shares held
- 13.19M
- Total value held
- $81.42M
- Institutional holders
- 124
- Unknown1.51M
- Unknown1.16M
- Unknown888.0K
- Unknown729.4K
- Unknown685.4K
- Unknown656.3K
- Unknown615.0K
- Unknown601.9K
- Unknown563.6K
- Unknown477.8K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
OptimizeRx Expands Ad Reach via OpenPath Deal with The Trade Desk
OptimizeRx has announced a partnership with The Trade Desk that uses its OpenPath platform to add authenticated healthcare professional reach to the ad network. The deal is expected to broaden the company’s inventory and provide advertisers with more precise targeting in the healthcare space. This collaboration follows a series of moves to grow OptimizeRx’s presence in the digital advertising market.
OptimizeRx Expands Ad Reach via OpenPath Deal with The Trade Desk. OptimizeRx has announced a partnership with The Trade Desk that uses its OpenPath platform to add authenticated healthcare professional reach to the ad network. The deal is expected to broaden the company’s inventory and provide advertisers with more precise targeting in the healthcare space. This collaboration follows a series of moves to grow OptimizeRx’s presence in the digital advertising market.